Quarterly ResultAug 6, 2026, 05:25 PM
Beauty Health Q2 Net Loss $(2.67)M, Sales $72.11M; $18M Legal Settlement
AI Summary
Beauty Health Co. reported a net loss of $(2.67) million for Q2 2026, a significant reversal from the $19.71 million net income in Q2 2025, with net sales declining 7.77% to $72.11 million. Year-to-date, the company used $(2.88) million in operating cash, contrasting with $12.64 million provided in the prior year. The company also announced preliminary settlements for both a Securities Class Action and a Customer Class Action, with the former totaling $18.0 million.
Key Highlights
- Q2 2026 net sales decreased 7.77% to $72.11 million from $78.19 million in Q2 2025.
- Q2 2026 net loss was $(2.67) million, a significant decline from $19.71 million net income in Q2 2025.
- Basic EPS for Q2 2026 was $(0.02), down from $0.16 in Q2 2025.
- Year-to-date 2026 net cash used for operating activities was $(2.88) million, compared to $12.64 million provided in YTD 2025.
- Company reached a preliminary settlement in the Securities Class Action for $18.0 million, with the company paying $3.0 million.
- Preliminary approval was granted for a settlement in the Customer Class Action.
- Cash, cash equivalents, and restricted cash decreased to $206.07 million from $232.67 million at year-end 2025.
- Amended principal executive office lease increased future operating lease payments by $14 million.
Price Impact
More from SKIN